Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP)-PAR 20-280, Cooperative Research Agreements Related to the World Trade Center Health Program (U01); RFA-OH-24-002, Exploratory/Developmental Grants on Lifestyle Medicine Research Related to the World Trade Center Health Program (R21); RFA-OH-24-003, Exploratory/Developmental Grants Related to the World Trade Center Survivors (R21-No Applications With Responders Accepted); and RFA-OH-24-004, World Trade Center Health Program Mentored Research Scientist Career Development Award (K01); Cancellation of Meeting, 20974-20975 [2024-06304]

Download as PDF 20974 Federal Register / Vol. 89, No. 59 / Tuesday, March 26, 2024 / Notices acquirers of divested assets to assess the effectiveness of these divestitures. In 2023, 2022, and 2021, the Commission issued 9, 14, and 6 orders, respectively, and a few required divestitures. For interviews with purchasers of divested assets, each interview typically takes less than one hour to complete. FTC staff estimates that it takes each participant no more than one hour to prepare for the interview. Accordingly, staff estimates that, for each interview, two individuals (typically a company executive and an attorney) will devote two hours each (one hour preparing and one hour participating) to responding to questions for a total of four hours. Assuming that staff evaluates approximately 4 divestitures per year during the three-year clearance period, staff estimates that the total hours burden will be 16 hours per year (4 divestiture reviews × 4 hours for preparing and participating). Staff may include approximately two monitor interviews a year, which would add at most 4 hours (2 interviews × 2 hours for preparing and participating). Interviews of monitors typically involve only the monitor and take approximately one hour to complete with no more than one hour to prepare for the interview. At most, this yields a total burden of 24 burden hours per year. Staff estimates that the total annual labor cost, based on an estimated average of $150/hour for executive and attorney wages, would be $3,600 (24 hours × $150). There are no capital, start-up, operation, maintenance, or other similar costs to respondents. ddrumheller on DSK120RN23PROD with NOTICES1 Request for Comment Pursuant to Section 3506(c)(2)(A) of the PRA, the FTC invites comments on: (1) whether the disclosure and recordkeeping requirements are necessary, including whether the information will be practically useful; (2) the accuracy of our burden estimates, including whether the methodology and assumptions used are valid; (3) ways to enhance the quality, utility, and clarity of the information to be collected; and (4) ways to minimize the burden of the collection of information. For the FTC to consider a comment, we must receive it on or before May 28, 2024. Your comment, including your name and your state, will be placed on the public record of this proceeding, including the https:// www.regulations.gov website. You can file a comment online or on paper. Due to heightened security screening, postal mail addressed to the Commission will be subject to delay. We encourage you to submit your comments VerDate Sep<11>2014 18:10 Mar 25, 2024 Jkt 262001 online through the https:// www.regulations.gov website. If you file your comment on paper, write ‘‘Administrative Activities, PRA Comment, P085405,’’ on your comment and on the envelope, and mail it to the following address: Federal Trade Commission, Office of the Secretary, 600 Pennsylvania Avenue NW, Suite CC–5610 (Annex J), Washington, DC 20580. Because your comment will become publicly available at https:// www.regulations.gov, you are solely responsible for making sure that your comment does not include any sensitive or confidential information. In particular, your comment should not include any sensitive personal information, such as your or anyone else’s Social Security number; date of birth; driver’s license number or other state identification number, or foreign country equivalent; passport number; financial account number; or credit or debit card number. You are also solely responsible for making sure that your comment does not include any sensitive health information, such as medical records or other individually identifiable health information. In addition, your comment should not include any ‘‘trade secret or any commercial or financial information which . . . is privileged or confidential’’—as provided by section 6(f) of the FTC Act, 15 U.S.C. 46(f), and FTC Rule 4.10(a)(2), 16 CFR 4.10(a)(2)— including, in particular, competitively sensitive information, such as costs, sales statistics, inventories, formulas, patterns, devices, manufacturing processes, or customer names. Comments containing material for which confidential treatment is requested must (1) be filed in paper form, (2) be clearly labeled ‘‘Confidential,’’ and (3) comply with FTC Rule 4.9(c). In particular, the written request for confidential treatment that accompanies the comment must include the factual and legal basis for the request, and must identify the specific portions of the comment to be withheld from the public record. See FTC Rule 4.9(c). Your comment will be kept confidential only if the General Counsel grants your request in accordance with the law and the public interest. Once your comment has been posted publicly at www.regulations.gov, we cannot redact or remove your comment unless you submit a confidentiality request that meets the requirements for such treatment under FTC Rule 4.9(c), and the General Counsel grants that request. The FTC Act and other laws that the Commission administers permit the PO 00000 Frm 00035 Fmt 4703 Sfmt 4703 collection of public comments to consider and use in this proceeding as appropriate. The Commission will consider all timely and responsive public comments that it receives on or before May 28, 2024. For information on the Commission’s privacy policy, including routine uses permitted by the Privacy Act, see https://www.ftc.gov/ site-information/privacy-policy. Josephine Liu, Assistant General Counsel for Legal Counsel. [FR Doc. 2024–06351 Filed 3–25–24; 8:45 am] BILLING CODE 6750–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP)—PAR 20–280, Cooperative Research Agreements Related to the World Trade Center Health Program (U01); RFA–OH–24– 002, Exploratory/Developmental Grants on Lifestyle Medicine Research Related to the World Trade Center Health Program (R21); RFA–OH–24– 003, Exploratory/Developmental Grants Related to the World Trade Center Survivors (R21—No Applications With Responders Accepted); and RFA–OH– 24–004, World Trade Center Health Program Mentored Research Scientist Career Development Award (K01); Cancellation of Meeting Centers for Disease Control and Prevention, Department of Health and Human Services. ACTION: Notice. AGENCY: Notice is hereby given of a change in the meeting of the Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP)—PAR 20–280, Cooperative Research Agreements Related to the World Trade Center Health Program (U01); RFA–OH–24– 002, Exploratory/Developmental Grants on Lifestyle Medicine Research Related to the World Trade Center Health Program (R21); RFA–OH–24–003, Exploratory/Developmental Grants Related to the World Trade Center Survivors (R21—No Applications with Responders Accepted); and RFA–OH– 24–004, World Trade Center Health Program Mentored Research Scientist Career Development Award (K01); March 19–21, 2024, 11 a.m.–6 p.m., EDT, video-assisted meeting, in the original Federal Register notice. The SUPPLEMENTARY INFORMATION: E:\FR\FM\26MRN1.SGM 26MRN1 Federal Register / Vol. 89, No. 59 / Tuesday, March 26, 2024 / Notices meeting notice was published in the Federal Register on December 20, 2023, Volume 88, Number 243, pages 88082– 88083. This meeting is being canceled in its entirety. FOR FURTHER INFORMATION CONTACT: Laurel Garrison, M.P.H., Scientific Review Officer, Office of Extramural Programs, National Institute for Occupational Safety and Health, Centers for Disease Control and Prevention, 5555 Ridge Avenue, Cincinnati, Ohio 45213. Telephone: (513) 533–8324; Email: LGarrison@cdc.gov. The Director, Office of Strategic Business Initiatives, Office of the Chief Operating Officer, Centers for Disease Control and Prevention, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry. Kalwant Smagh, Director, Office of Strategic Business Initiatives, Office of the Chief Operating Officer, Centers for Disease Control and Prevention. [FR Doc. 2024–06304 Filed 3–25–24; 8:45 am] BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Medicare & Medicaid Services [CMS–7074–N] Announcement of the Advisory Panel on Outreach and Education (APOE) InPerson Meeting Centers for Medicare & Medicaid Services (CMS), Health and Human Services (HHS). ACTION: Notice. AGENCY: This notice announces the next meeting of the APOE (the Panel) in accordance with the Federal Advisory Committee Act. The Panel advises and makes recommendations to the Secretary of the U.S. Department of Health and Human Services (HHS) (the Secretary) and the Administrator of the Centers for Medicare & Medicaid Services (CMS) on opportunities to enhance the effectiveness of consumer education strategies concerning the Health Insurance Marketplace®, Medicare, Medicaid, and the Children’s Health Insurance Program (CHIP). This meeting is open to the public. ddrumheller on DSK120RN23PROD with NOTICES1 SUMMARY: VerDate Sep<11>2014 18:10 Mar 25, 2024 Jkt 262001 Meeting Date: Thursday, April 18, 2024 from 12 p.m. to 5 p.m. eastern daylight time (e.d.t). Deadline for Meeting Registration, Presentations, Special Accommodations, and Comments: Thursday, April 4, 2024 5 p.m. (EDT). ADDRESSES: Meeting Location: U.S. Department of Health & Human Services, Hubert H. Humphrey Building, 200 Independence Avenue SW, Washington, DC 20201. Presentations and Written Comments: Presentations and written comments should be submitted to: Walt Gutowski, Designated Federal Official (DFO), Office of Communications, Centers for Medicare & Medicaid Services, 7500 Security Boulevard, Mailstop S1–04–08, Baltimore, MD 21244–1850, 410–786– 6818, or via email at APOE@ cms.hhs.gov. Registration: Persons wishing to attend this meeting must register at the website https://CMS-APOE-April2024. rsvpify.com or by contacting the DFO listed in the FOR FURTHER INFORMATION CONTACT section of this notice, by the date listed in the DATES section of this notice. Individuals requiring sign language interpretation or other special accommodations should contact the DFO at the address listed in the ADDRESSES section of this notice by the date listed in the DATES section of this notice. FOR FURTHER INFORMATION CONTACT: Walt Gutowski, Designated Federal Official, Office of Communications, 7500 Security Boulevard, Mailstop S1–04–08, Baltimore, MD 21244–1850, 410–786– 6818, or via email at APOE@ cms.hhs.gov. Additional information about the APOE is available at: https:// www.cms.gov/Regulations-andGuidance/Guidance/FACA/APOE. Press inquiries are handled through the CMS Press Office at (202) 690–6145. SUPPLEMENTARY INFORMATION: DATES: I. Background and Charter Renewal Information A. Background The Advisory Panel for Outreach and Education (APOE) (the Panel) is governed by the provisions of the Federal Advisory Committee Act (FACA) (Pub. L. 92–463), as amended (5 U.S.C. appendix 2), which sets forth standards for the formation and use of Federal advisory committees. The Panel is authorized by section 1114(f) of the Social Security Act (the Act) (42 U.S.C. 1314(f)) and section 222 of the Public Health Service Act (42 U.S.C. 217a). The Panel, which was first chartered in 1999, advises and makes PO 00000 Frm 00036 Fmt 4703 Sfmt 4703 20975 recommendations to the Secretary of the U.S. Department of Health and Human Services (the Department) and the Administrator of the Centers for Medicare & Medicaid Services (CMS) on the effective implementation of national Medicare, Medicaid, Children’s Health Insurance Program (CHIP) and Health Insurance Marketplace outreach and education programs. The APOE has focused on a variety of laws, including the Medicare Modernization Act of 2003 (Pub. L. 108– 173), and the Affordable Care Act (Patient Protection and Affordable Care Act, (Pub. L. 111–148) and Health Care and Education Reconciliation Act of 2010 (Pub. L. 111–152)). The APOE helps the Department determine the best communication channels and tactics for various programs and priorities, as well as new rules and laws. In the coming years, we anticipate the American Rescue Plan, the Inflation Reduction Act, and the SUPPORT Act will be some of the topics the Panel will discuss. The Panel will provide feedback to CMS staff on outreach and education strategies, communication tools and messages and how to best reach minority, vulnerable and Limited English Proficiency populations. B. Charter Renewal The Panel’s charter was renewed on January 19, 2023, and will terminate on January 19, 2025, unless renewed by appropriate action. The Charter can be found at https://www.cms.gov/ regulations-and-guidance/guidance/ faca/apoe. In accordance with the renewed charter, the APOE will advise the Secretary and the CMS Administrator concerning optimal strategies for the following: • Developing and implementing education and outreach programs for individuals enrolled in, or eligible for, Medicare, Medicaid, the CHIP, and coverage available through the Health Insurance Marketplace® and other CMS programs. • Enhancing the Federal Government’s effectiveness in informing Medicare, Medicaid, CHIP, or the Health Insurance Marketplace® consumers, issuers, providers, and stakeholders, pursuant to education and outreach programs regarding these programs, including public-private partnerships to leverage the resources of the private sector in educating beneficiaries, providers, partners and stakeholders. • Expanding outreach to minority and underserved communities, including racial and ethnic minorities, in the context of Medicare, Medicaid, CHIP, E:\FR\FM\26MRN1.SGM 26MRN1

Agencies

[Federal Register Volume 89, Number 59 (Tuesday, March 26, 2024)]
[Notices]
[Pages 20974-20975]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2024-06304]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Disease, Disability, and Injury Prevention and Control Special 
Emphasis Panel (SEP)--PAR 20-280, Cooperative Research Agreements 
Related to the World Trade Center Health Program (U01); RFA-OH-24-002, 
Exploratory/Developmental Grants on Lifestyle Medicine Research Related 
to the World Trade Center Health Program (R21); RFA-OH-24-003, 
Exploratory/Developmental Grants Related to the World Trade Center 
Survivors (R21--No Applications With Responders Accepted); and RFA-OH-
24-004, World Trade Center Health Program Mentored Research Scientist 
Career Development Award (K01); Cancellation of Meeting

AGENCY: Centers for Disease Control and Prevention, Department of 
Health and Human Services.

ACTION: Notice.

-----------------------------------------------------------------------

SUPPLEMENTARY INFORMATION: Notice is hereby given of a change in the 
meeting of the Disease, Disability, and Injury Prevention and Control 
Special Emphasis Panel (SEP)--PAR 20-280, Cooperative Research 
Agreements Related to the World Trade Center Health Program (U01); RFA-
OH-24-002, Exploratory/Developmental Grants on Lifestyle Medicine 
Research Related to the World Trade Center Health Program (R21); RFA-
OH-24-003, Exploratory/Developmental Grants Related to the World Trade 
Center Survivors (R21--No Applications with Responders Accepted); and 
RFA-OH-24-004, World Trade Center Health Program Mentored Research 
Scientist Career Development Award (K01); March 19-21, 2024, 11 a.m.-6 
p.m., EDT, video-assisted meeting, in the original Federal Register 
notice. The

[[Page 20975]]

meeting notice was published in the Federal Register on December 20, 
2023, Volume 88, Number 243, pages 88082-88083.
    This meeting is being canceled in its entirety.

FOR FURTHER INFORMATION CONTACT: Laurel Garrison, M.P.H., Scientific 
Review Officer, Office of Extramural Programs, National Institute for 
Occupational Safety and Health, Centers for Disease Control and 
Prevention, 5555 Ridge Avenue, Cincinnati, Ohio 45213. Telephone: (513) 
533-8324; Email: [email protected].
    The Director, Office of Strategic Business Initiatives, Office of 
the Chief Operating Officer, Centers for Disease Control and 
Prevention, has been delegated the authority to sign Federal Register 
notices pertaining to announcements of meetings and other committee 
management activities, for both the Centers for Disease Control and 
Prevention and the Agency for Toxic Substances and Disease Registry.

Kalwant Smagh,
Director, Office of Strategic Business Initiatives, Office of the Chief 
Operating Officer, Centers for Disease Control and Prevention.
[FR Doc. 2024-06304 Filed 3-25-24; 8:45 am]
BILLING CODE 4163-18-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.